Phreesia Inc. $(PHR)$ reported its financial results for the first quarter of fiscal 2026, ended April 30, 2025. The company achieved total revenue of $115.9 million, marking a 15% increase compared to the same period last year. The average number of healthcare services clients (AHSCs) rose to 4,411, up 9% year-over-year, while total revenue per AHSC increased by 6% to $26,283. Phreesia recorded a net loss of $3.9 million in the quarter, an improvement from the net loss of $19.7 million reported in the previous year. Adjusted EBITDA showed a significant increase to $20.8 million from $4.1 million in the first quarter of the prior year. The company generated $14.9 million in net cash from operating activities, compared to a net cash usage of $0.7 million in the same period last year, and achieved a free cash flow of $7.5 million, improving from negative $6.2 million. For fiscal 2026, Phreesia maintains its revenue outlook, projecting a range between $472 million and $482 million, excluding potential future acquisitions. The company has updated its Adjusted EBITDA outlook to a range of $85 million to $90 million, up from the previous range of $78 million to $88 million, citing expected improvements in operating efficiency. As of April 30, 2025, Phreesia reported cash and cash equivalents totaling $90.9 million, an increase of $6.7 million since January 31, 2025.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.